Immutable evidence record · ticker

Regeneron Pharmaceuticals, Inc. (REGN34)

Published as observed on 17 August 2026 at 21:19 BST.

Regeneron Pharmaceuticals, Inc. has a balanced company news read. Its latest completed weekly trend is negative.

As of
17 Aug 2026, 21:19
Scope
company and instrument
Evidence
9 items
Independent sources
2
Country
Brazil
Sector
Healthcare
Previous read
48.000
Change

Verification

Evidence & related research

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Regeneron Pharmaceuticals, Inc. (REGN34), 2026-08-17, https://sharemaestro.com/evidence/5df4d079-fcdb-4002-b373-dadc820524af/
Record checksum 3d51b66ff04950aafe1c1a4135248ecbcedb02981eece322bb8f93cf2791b112

Evidence context